Related Experiment Video
Updated: Aug 24, 2026
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Reversibility of oncogene-induced cancer
1Division of Oncology, Department of Medicine, Stanford University, CCSR 1105B, 269 Campus Drive, Stanford, CA 94305-5151, USA. dfelsher@stanford.edu
Abstract:
Cancer can largely be conceived as a consequence of genomic catastrophes resulting in genetic events that usurp physiologic function of a normal cell. These genetic events mediate their pathologic effects by either activating oncogenes or inactivating tumor-suppressor genes. The targeted repair or inactivation of these damaged gene products may counteract the effects of these genetic events, reversing tumorigenesis and thereby serve as an effective therapy for cancer. However, because they are the result of many genetic events, the inactivation of no single mutant gene product may be sufficient to reverse cancer. Despite this caveat, compelling recent evidence suggests that there are circumstances when even the brief interruption of activation of a single oncogene can be sufficient to reverse tumorigenesis. Understanding how and when oncogene inactivation reverses cancer will be important in both defining the molecular pathogenesis of cancer as well as developing new molecularly based treatments.
Insights
Cancer arises from genetic events that activate oncogenes or inactivate tumor-suppressor genes. Interrupting a single oncogene
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer develops from genetic alterations that disrupt normal cell function by activating oncogenes or inactivating tumor-suppressor genes.
- Targeted therapies aim to counteract these genetic events by repairing or inactivating damaged gene products to reverse tumorigenesis.
- The complexity of cancer, resulting from multiple genetic events, often means single gene product inactivation may not be sufficient for reversal.
Purpose of the Study:
- To investigate the circumstances under which the interruption of a single oncogene's activation can reverse cancer.
- To understand the mechanisms by which oncogene inactivation leads to cancer reversal.
- To explore the implications of these findings for developing novel molecularly targeted cancer therapies.
Main Methods:
- Review of recent compelling evidence on oncogene inactivation in cancer reversal.
- Analysis of molecular pathways involved in oncogene activation and tumor suppression.
- Exploration of genetic events leading to cancer pathogenesis.
Main Results:
- Emerging evidence indicates that brief interruption of a single oncogene's activation can, in specific contexts, reverse tumorigenesis.
- The study highlights the critical role of oncogene signaling in cancer development and progression.
- Understanding these specific contexts is key to therapeutic intervention.
Conclusions:
- Targeting single oncogenes, even transiently, shows potential for cancer therapy.
- Further research into the precise mechanisms and conditions for oncogene inactivation-mediated cancer reversal is crucial.
- This understanding will advance both the molecular pathogenesis of cancer and the development of targeted treatments.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
12:04Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Related Concept Videos
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:51Mechanisms of Retrovirus-induced Cancers